Sumit Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sumit Kumar has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Ritesh Kumar
Department of Radiation Oncology, Rutgers Cancer Institute, New Brunswick, NJ 08901, USA
4 shared publications - Ajay Gogia
Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India
2 shared publications Biswajit Dey
Department of Pathology, NEIGRIHMS, Shillong, Meghalaya, India
2 shared publications- Biswajit Dey
Pathology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, IND
2 shared publications - Pranjal Kalita
Pathology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, IND
2 shared publications - Prashanth Giridhar
Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai
2 shared publications
Latest Publications
- 25 March 2026
- Published by Wolters Kluwer Health in Journal of Radiation and Cancer Research
Primary Intracranial Ewing’s Sarcoma of the Right Frontoparietal Region: A Rare Case Report
A BSTRACT: Ewing’s sarcoma (ES) is a malignant tumor arising from the bones and soft tissues in children and young adults. However, primary intracranial ES is extremely rare, and they generally present as supratentorial or intraparenchymal tumors. There are no standard treatment guidelines for such cases, with each patient being managed on a case-by-case basis. This paper reports a case of a 15-year-old female patient who presented with a complaint of headache and vomiting. Radiology suggested an intracranial mass in the right frontoparietal region with thinning of the adjacent overlying bone. She underwent right frontal craniotomy with tumor excision, which, after histopathological examination and immunohistochemistry, showed features consistent with ES. She was managed with multiagent chemotherapy.
- 25 March 2026
- Published by Wolters Kluwer Health in Journal of Radiation and Cancer Research
Primary Intracranial Ewing’s Sarcoma of the Right Frontoparietal Region: A Rare Case Report
A BSTRACT: Ewing’s sarcoma (ES) is a malignant tumor arising from the bones and soft tissues in children and young adults. However, primary intracranial ES is extremely rare, and they generally present as supratentorial or intraparenchymal tumors. There are no standard treatment guidelines for such cases, with each patient being managed on a case-by-case basis. This paper reports a case of a 15-year-old female patient who presented with a complaint of headache and vomiting. Radiology suggested an intracranial mass in the right frontoparietal region with thinning of the adjacent overlying bone. She underwent right frontal craniotomy with tumor excision, which, after histopathological examination and immunohistochemistry, showed features consistent with ES. She was managed with multiagent chemotherapy.
- Open Access
- 31 December 2025
- Published by Nepal Journals Online (JOL) in Journal of Pathology of Nepal
- Vol. 15 (2) , 2411-2416
Unveiling a Malignant Oncocytic Adrenocortical Carcinoma: A clinico-radiological challenge resolved by immunohistology and a brief review of literature
Oncocytic adrenocortical carcinoma (OACC) is a rare histopathological variant of adrenocortical carcinoma, a malignant tumor of adrenal cortical cells. The exact incidence of this unusual variant of ACC is unknown. It mainly occurs in the 5th decade of life with no gender predilection, without any established risk factor, and is characterised by the majority (>90%) of the tumor cells displaying oncocytic morphology. The patients mostly present with an abdominal mass with associated mass effects, or as an incidental finding detected during radiological evaluation for other reasons, and or occasionally with a functional status, usually hypercortisolism. It is an indolent variant with a lower stage, rare local invasion, delayed recurrence, and improved survivability, by virtue of which it differs from conventional adrenocortical carcinomas both clinically and prognostically. We present a case of non-functional left-sided oncocytic adrenocortical carcinoma in a 40-year-old female who was diagnosed radiologically as a high-grade malignancy, whereas histomorphology, along with immunohistochemistry, played a key role in diagnosis as OACC.
- 31 December 2025
- Published by Nepal Journals Online (JOL) in Journal of Pathology of Nepal
- Vol. 15 (2) , 2411-2416
Open AccessUnveiling a Malignant Oncocytic Adrenocortical Carcinoma: A clinico-radiological challenge resolved by immunohistology and a brief review of literature
Oncocytic adrenocortical carcinoma (OACC) is a rare histopathological variant of adrenocortical carcinoma, a malignant tumor of adrenal cortical cells. The exact incidence of this unusual variant of ACC is unknown. It mainly occurs in the 5th decade of life with no gender predilection, without any established risk factor, and is characterised by the majority (>90%) of the tumor cells displaying oncocytic morphology. The patients mostly present with an abdominal mass with associated mass effects, or as an incidental finding detected during radiological evaluation for other reasons, and or occasionally with a functional status, usually hypercortisolism. It is an indolent variant with a lower stage, rare local invasion, delayed recurrence, and improved survivability, by virtue of which it differs from conventional adrenocortical carcinomas both clinically and prognostically. We present a case of non-functional left-sided oncocytic adrenocortical carcinoma in a 40-year-old female who was diagnosed radiologically as a high-grade malignancy, whereas histomorphology, along with immunohistochemistry, played a key role in diagnosis as OACC.
- 6 May 2025
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 7 (1) , 1-4
Primary Conjunctival Lymphoma Presenting as Conjunctivitis: A Case Report
- 6 May 2025
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 7 (1) , 1-4
Primary Conjunctival Lymphoma Presenting as Conjunctivitis: A Case Report
- 29 February 2024
- Published by Springer Nature in International Cancer Conference Journal
- Vol. 13 (2) , 167-170
Capecitabine and oxaliplatin induced Steven–Johnson syndrome following nivolumab in a patient of metastatic esophageal carcinoma
Stevens–Johnson syndrome presents as mucocutaneous blistering and sloughing, which may follow a devastating clinical course. Although Stevens–Johnson syndrome has been reported following the administration of anticancer drugs, only a few cases induced by cytotoxic anticancer drugs, administered after immune checkpoint inhibitors, have been reported. The present report describes a case of Stevens–Johnson syndrome caused by capecitabine and oxaliplatin (CAPEOX) combination chemotherapy, in a patient with esophageal squamous cell carcinoma, who had been previously treated with nivolumab.
- 29 February 2024
- Published by Springer Nature in International Cancer Conference Journal
- Vol. 13 (2) , 167-170
Capecitabine and oxaliplatin induced Steven–Johnson syndrome following nivolumab in a patient of metastatic esophageal carcinoma
Stevens–Johnson syndrome presents as mucocutaneous blistering and sloughing, which may follow a devastating clinical course. Although Stevens–Johnson syndrome has been reported following the administration of anticancer drugs, only a few cases induced by cytotoxic anticancer drugs, administered after immune checkpoint inhibitors, have been reported. The present report describes a case of Stevens–Johnson syndrome caused by capecitabine and oxaliplatin (CAPEOX) combination chemotherapy, in a patient with esophageal squamous cell carcinoma, who had been previously treated with nivolumab.
- Open Access
- 9 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20287
Challenges and Outcomes of COVID-19 Positive Neurosurgical Patients: An Institutional Experience With Emphasis on Modifications of Neurosurgical Practice
Introduction: There has been a drastic reduction in the number of neurosurgeries performed during the COVID-19 pandemic due to a multitude of challenges prompting restructuring of neurosurgical services. The present study describes the challenges and outcomes of non-elective neurosurgical procedures done on COVID-19 positive patients along with the modifications in neurosurgical practice during the pandemic. Methods: A retrospective study was done in the Department of Neurosurgery over a period of one year and three months. Demographic and clinical details including outcomes of the COVID-19 positive patients, who had undergone non-elective neurosurgical interventions, were collected. Results: Ten patients (3.8%) were COVID-19 positive out of 262 neurosurgical interventions done. The age of the patients ranged from 5 days to 78 years with five males and five females. Out of the 10 patients, five were neurotrauma cases including one patient of head injury with craniovertebral junction injury. The patient with craniovertebral junction injury underwent foramen magnum decompression with C1 lateral mass-C2 pedicle screw on the right and C0-C2 pedicle screw and rod fixation on the left. The rest of the neurotrauma cases underwent craniotomy or burr-hole craniostomy followed by evacuation. Only one patient (10%) had postoperative 30-day mortality. The rest nine patients (90%) survived the post-operative 30-day mortality. The various modifications incorporated in the neurosurgical practice included categorizing the emergency room into various zones, a separate operating theatre for COVID-19 patients, limiting the number of operating members as well as minor modifications in the operating procedures. Conclusions: The postoperative surgical outcome is favorable in COVID-19 positive patients with modifications of the existing neurosurgical practices.
- 9 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20287
Open AccessChallenges and Outcomes of COVID-19 Positive Neurosurgical Patients: An Institutional Experience With Emphasis on Modifications of Neurosurgical Practice
Introduction: There has been a drastic reduction in the number of neurosurgeries performed during the COVID-19 pandemic due to a multitude of challenges prompting restructuring of neurosurgical services. The present study describes the challenges and outcomes of non-elective neurosurgical procedures done on COVID-19 positive patients along with the modifications in neurosurgical practice during the pandemic. Methods: A retrospective study was done in the Department of Neurosurgery over a period of one year and three months. Demographic and clinical details including outcomes of the COVID-19 positive patients, who had undergone non-elective neurosurgical interventions, were collected. Results: Ten patients (3.8%) were COVID-19 positive out of 262 neurosurgical interventions done. The age of the patients ranged from 5 days to 78 years with five males and five females. Out of the 10 patients, five were neurotrauma cases including one patient of head injury with craniovertebral junction injury. The patient with craniovertebral junction injury underwent foramen magnum decompression with C1 lateral mass-C2 pedicle screw on the right and C0-C2 pedicle screw and rod fixation on the left. The rest of the neurotrauma cases underwent craniotomy or burr-hole craniostomy followed by evacuation. Only one patient (10%) had postoperative 30-day mortality. The rest nine patients (90%) survived the post-operative 30-day mortality. The various modifications incorporated in the neurosurgical practice included categorizing the emergency room into various zones, a separate operating theatre for COVID-19 patients, limiting the number of operating members as well as minor modifications in the operating procedures. Conclusions: The postoperative surgical outcome is favorable in COVID-19 positive patients with modifications of the existing neurosurgical practices.
- 15 February 2020
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (S1) , 96-101
Primary Broad Ligament Leiomyosarcoma: a Rare Case Report with Review of Literature
- 15 February 2020
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (S1) , 96-101
Primary Broad Ligament Leiomyosarcoma: a Rare Case Report with Review of Literature
- 11 January 2020
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (S1) , 40-43
Bell’s Palsy in a Treated Case of Breast Cancer—a Rare Presentation of Recurrence
- 11 January 2020
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 11 (S1) , 40-43
Bell’s Palsy in a Treated Case of Breast Cancer—a Rare Presentation of Recurrence
- 1 April 2019
- Published by Elsevier in Current Problems in Cancer
- Vol. 43 (2) , 130-134
Laryngeal metastases from breast cancer: A rare clinical entity
- 1 April 2019
- Published by Elsevier in Current Problems in Cancer
- Vol. 43 (2) , 130-134
Laryngeal metastases from breast cancer: A rare clinical entity
- 2 May 2018
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 50 (3) , 674-677
Esophageal Metastases from Breast Carcinoma: a Rare Delayed Metastases After 15 Years
- 2 May 2018
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 50 (3) , 674-677
Esophageal Metastases from Breast Carcinoma: a Rare Delayed Metastases After 15 Years